Skip to main content
. 2017 Apr 11;18:172. doi: 10.1186/s13063-017-1919-2

Table 2.

Interventions according to groups

Group Type Intranasal Oral
A Experimental Ketamine (4.0 mg/kg, maximum 100 mg)a + midazolam (0.2 mg/kg, maximum 5.0 mg)b Placebo
B Drug route comparison Placebo Ketamine (4.0 mg/kg, maximum 100 mg)a + midazolam (0.5 mg/kg, maximum 20 mg)c
C Control Placebo Midazolam (1.0 mg/kg, maximum 20 mg)c

aInjectable solution in a concentration of 50.0 mg/mL (Ketamin S, Cristalia, Sao Paulo, Brazil

bInjectable solution in a concentration of 5.0 mg/mL (Dormire solução injetável, Cristalia, Sao Paulo, Brazil)

cOral solution in a concentration of 2.0 mg/mL (Dormire solução oral, Cristalia, Sao Paulo, Brazil)